Skip to main
OSCR

Oscar Health (OSCR) Stock Forecast & Price Target

Oscar Health (OSCR) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 0%
Buy 14%
Hold 57%
Sell 14%
Strong Sell 14%

Bulls say

Oscar Health Inc. demonstrated a significant year-over-year revenue increase of 29.0%, reaching $2.86 billion in the second quarter of 2025, attributed to strong customer retention and member additions. The company's medical loss ratio (MLR) improved to 91.1%, better than consensus expectations, indicating efficient management of healthcare costs despite increasing market morbidity. Additionally, projected enrollment weighted direct policy premiums per member per month (PMPM) are expected to rise by 28.5% in 2026 and 16.9% in 2027, reflecting robust growth potential in its insurance offerings.

Bears say

Oscar Health's stock outlook appears negative due to anticipated declines in enrollment in the Individual ACA Marketplace, with projections indicating a potential decrease of 20% to 30% in CY26, translating to a loss of approximately 6.1 million members year-over-year. The company's strategy to shift its insurance mix towards Bronze plans, while notable, may not offset the adverse impact of reduced enrollment and potential attrition among healthier members in a cost-cutting environment. Additionally, despite a slight improvement in SG&A ratios and an adjusted EBITDA margin of 2.4%, the overall financial health may remain under pressure if market conditions deteriorate further.

Oscar Health (OSCR) has been analyzed by 7 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 14% recommend Buy, 57% suggest Holding, 14% advise Selling, and 14% predict a Strong Sell.

This aggregate rating is based on analysts' research of Oscar Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Oscar Health (OSCR) Forecast

Analysts have given Oscar Health (OSCR) a Hold based on their latest research and market trends.

According to 7 analysts, Oscar Health (OSCR) has a Hold consensus rating as of Jan 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Oscar Health (OSCR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.